Department of Neurosurgery, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, 130 East 77th Street, 3rd Floor Black Hall Building, New York, NY, 10075, USA.
Department of Biomedical Engineering, The Aldar and Iby Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Neurosurg Rev. 2022 Jun;45(3):2481-2487. doi: 10.1007/s10143-022-01767-7. Epub 2022 Mar 24.
Glioblastoma multiforme (GBM) patients continue to suffer a poor prognosis. The blood brain barrier (BBB) comprises one of the obstacles for therapy, creating a barrier that decreases the bioavailability of chemotherapeutic agents in the central nervous system. Previously, a vascularized temporoparietal fascial scalp flap (TPFF) lining the resection cavity was introduced in a trial conducted in our institution, in newly-diagnosed GBM patients in an attempt to bypass the BBB after initial resection. In this paper, we report on a new technique to bypass the BBB after re-resection and potentially to allow tumor antigens to be surveilled by the immune system. The study aims to assess the feasibility of performing a cranial transposition and revascularization of autologous omentum after re-resection of GBM. Laparoscopically harvested omental free flap was transposed to the resection cavity by a team consisting of neurosurgeons, otolaryngologists, and general surgeons. This was done as part of a single center, single arm, open-label, phase I study. Autologous abdominal omental tissue was harvested laparoscopically on its vascularized pedicle in 2 patients, transposed as a free flap, revascularized using external carotid artery, and carefully laid into the tumor resection cavity. Patients did well postoperatively returning to baseline activities. Graft viability was confirmed by cerebral angiogram. Omental cranial transposition of a laparoscopically harvested, vascularized flap, into the cavity of re-resected GBM patients is feasible and safe in the short term. Further studies are needed to ascertain whether such technique can improve progression free survival and overall survival in these patients.
多形性胶质母细胞瘤(GBM)患者的预后仍然较差。血脑屏障(BBB)是治疗的障碍之一,它形成了一道屏障,降低了中枢神经系统中化疗药物的生物利用度。此前,我们机构在一项临床试验中引入了一种带血管的颞顶筋膜头皮瓣(TPFF)覆盖切除腔,旨在尝试在初次切除后绕过 BBB。在本文中,我们报告了一种新的技术,用于在再次切除后绕过 BBB,并可能允许免疫系统监测肿瘤抗原。该研究旨在评估在再次切除 GBM 后进行颅骨移位和自体大网膜再血管化的可行性。由神经外科医生、耳鼻喉科医生和普通外科医生组成的团队将腹腔镜采集的大网膜游离皮瓣转移到切除腔中。这是一项单中心、单臂、开放标签、I 期研究的一部分。在 2 名患者中,通过腹腔镜在其带血管蒂的大网膜上采集自体腹部大网膜组织,作为游离皮瓣转移,使用颈外动脉再血管化,并小心地置于肿瘤切除腔中。患者术后恢复良好,恢复到基线活动水平。脑动脉造影证实移植物存活。将腹腔镜采集的带血管游离皮瓣经颅移位到再次切除的 GBM 患者的腔中是可行的,在短期内是安全的。需要进一步的研究来确定这种技术是否可以改善这些患者的无进展生存期和总生存期。